Terms: = Endocrine gland cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
16 results:
1. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic cancer.
Ischyropoulou M; Sabljo K; Schneider L; Niemeyer CM; Napp J; Feldmann C; Alves F
Adv Mater; 2023 Nov; 35(46):e2305151. PubMed ID: 37587542
[TBL] [Abstract] [Full Text] [Related]
2. Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes With Radiation and PD-1 Blockade.
Zhuang Y; Wang Y; Liu C; Li S; Du S; Li G
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):894-905. PubMed ID: 36608830
[TBL] [Abstract] [Full Text] [Related]
3. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
[TBL] [Abstract] [Full Text] [Related]
4. The STING pathway: Therapeutic vulnerabilities in ovarian cancer.
Shakfa N; Li D; Nersesian S; Wilson-Sanchez J; Koti M
Br J Cancer; 2022 Sep; 127(4):603-611. PubMed ID: 35383278
[TBL] [Abstract] [Full Text] [Related]
5. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
[TBL] [Abstract] [Full Text] [Related]
6. Ovarian cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis.
de Queiroz NMGP; Xia T; Konno H; Barber GN
Mol Cancer Res; 2019 Apr; 17(4):974-986. PubMed ID: 30587523
[TBL] [Abstract] [Full Text] [Related]
7. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.
Kumazoe M; Takai M; Hiroi S; Takeuchi C; Yamanouchi M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Yamada S; Kangawa K; Takahashi T; Tanaka H; Tachibana H
Sci Rep; 2017 May; 7(1):1917. PubMed ID: 28507327
[TBL] [Abstract] [Full Text] [Related]
8. Nanoscale Coordination Polymers Codeliver Carboplatin and Gemcitabine for Highly Effective treatment of Platinum-Resistant Ovarian cancer.
Poon C; Duan X; Chan C; Han W; Lin W
Mol Pharm; 2016 Nov; 13(11):3665-3675. PubMed ID: 27712076
[TBL] [Abstract] [Full Text] [Related]
9. Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma.
Hoem D; Straume O; Immervoll H; Akslen LA; Molven A
APMIS; 2013 Nov; 121(11):1037-46. PubMed ID: 23489215
[TBL] [Abstract] [Full Text] [Related]
10. In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.
Ritchie D; Mileshkin L; Wall D; Bartholeyns J; Thompson M; Coverdale J; Lau E; Wong J; Eu P; Hicks RJ; Prince HM
Cancer Immunol Immunother; 2007 Feb; 56(2):155-63. PubMed ID: 16733671
[TBL] [Abstract] [Full Text] [Related]
11. [Influence of ACh on the level of protein kinase C, intracellular free Ca(2+) and cyclic AMP/cyclic gmp of cultured human pituitary adenoma cells].
Chi SM; Li CX; Liu YL; Zhu YL; Gu JW
Sheng Li Xue Bao; 2003 Apr; 55(2):165-70. PubMed ID: 12715105
[TBL] [Abstract] [Full Text] [Related]
12. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
Hill BT; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Bedford P
Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):75-83. PubMed ID: 2380098
[TBL] [Abstract] [Full Text] [Related]
14. Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?
Redman CW; Finn C; Ward K; Kelly K; Buxton EJ; Varma R; Shortland-Webb W; Luesley DM
Br J Cancer; 1990 May; 61(5):755-8. PubMed ID: 2159769
[TBL] [Abstract] [Full Text] [Related]
15. Cyclic gmp in urine to monitor the response to ovarian cancer to therapy.
Turner GA; Ellis RD; Guthrie D; Latner AL; Ross WM; Skillen AW
Br J Obstet Gynaecol; 1982 Sep; 89(9):760-4. PubMed ID: 6288064
[TBL] [Abstract] [Full Text] [Related]
16. Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic gmp: a potential marker for cancer treatment.
Turner GA; Ellis RD; Guthrie D; Latner AL; Monaghan JM; Ross WM; Skillen AW; Wilson RG
J Clin Pathol; 1982 Aug; 35(8):800-6. PubMed ID: 6286732
[TBL] [Abstract] [Full Text] [Related]
